|

Inovio pharmaceuticals inc ($INO) cycle nearly complete

The next entry in the theme of Corona Virus stocks is Inovio Pharmaceuticals Inc.  Inovio has had a steady advance during the COVID-19 spreading worldwide.  It also remains very technical as with all other stocks. Lets take a look at what they do as a company:

“The Inovio technology is based on inserting engineered DNA into cells where it becomes incorporated into proteins involved in the immune response to cancers and viruses by producing T cells and antibodies that aid recovery from infection. The technology can be “targeted” to specific types of cancer and immune diseases, such as those produced by a virus.”

Inovio has had an impressive rally so far this year.  The Elliott Wave view seems to be counting technically clean. Let’s take a look below at the Daily view.

Inovio Daily Elliott Wave

INO

Medium term term view from 10/02/2019 lows of 1.92. Wave ((1)) was set at 2.55 on 10/16/2019 and wave ((2)) at 2.09 on 10/31/2019.  From there, Inovio had some nesting which resulted in an extended wave ((3)).  Wave ((3)) is favoured to be set at 19.36 on 3/09/2019. The count is getting mature to start chasing new longs.  After a wave ((5)) of Red I is complete, a lengthy multi month correction may take place in 3,7 or 11 swings before more upside is expected to resume.

Risk Management

Using proper risk management is absolutely essential when trading or investing in a volatile stocks.  Elliott Wave counts can evolve quickly, be sure to have your stops in and define your risk when trading.

Author

Elliott Wave Forecast Team

Elliott Wave Forecast Team

ElliottWave-Forecast.com

More from Elliott Wave Forecast Team
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD meets some support near 1.1670

EUR/USD further extends its bearish leg on Wednesday, coming under extra pressure and breaching below the 1.1700 level to flirt with four-week troughs in a context of marginal gains in the US Dollar ahead of the key US NFP on Friday.

GBP/USD deflates to daily lows near 1.3470

GBP/USD stays under pressure on Wednesday, dipping to fresh lows around 1.3470 and extending the pullback that began the previous session. Cable remains on the defensive, with the US Dollar nudging slightly higher in the wake of key US December data.

Gold remains offered near $4,450

Gold remains on the back foot on Wednesday, hovering around $4,450 per troy ounce after bringing a three-day rally to an end. The metal’s advance seems to have run out of steam near the $4,500 area, with a firmer US Dollar after key US data weighing on prices. Still, the downside looks limited for now, thanks to falling US Treasury yields across the curve.

XRP faces selling pressure as key on-chain metric resets and ETF inflows weaken

Ripple (XRP) is trading downward but holding support at $2.22 at the time of writing on Wednesday, as fear spreads across the cryptocurrency market, reversing gains made from the start of the year.

2026 economic outlook: Clear skies but don’t unfasten your seatbelts yet

Most years fade into the background as soon as a new one starts. Not 2025: a year of epochal shifts, in which the macroeconomy was the dog that did not bark. What to expect in 2026? The shocks of 2025 will not be undone, but neither will they be repeated.

XRP battles selling pressure as profit-taking, ETF inflows shape outlook

Ripple (XRP) is trading downward but holding support at $2.22 at the time of writing on Wednesday, as fear spreads across the cryptocurrency market, reversing gains made from the start of the year.